Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal 
Pro at codon 15. We found that Ml and M2 were mutually exclusive, M3 was only found in association with Ml, and M4 was predominantly found in association with M2. AU patients with Ml but none of those with M2 had MO. The invariable coexistence of certain mutations in codon 15 and codons 28 and 29 and the mutual exclusion of other mutations in these two noncontiguous regions is related to the stem-oop structure of the pre-genome encapsidation sequence located in the precore/core region. M2 and M4 enhance the stability of the stem by providing two additional paired sites. Ml destroys an existing base pair. However, Ml only occurred in the presence of MO, which provides an extra paired site, and 50% of patients with Ml had M3, a compensatory mutation that restores base pairing at this site. Our data support the proposed secondary structure of the pre-genome encapsidation sequence. The primary function of the mutations in the pre-core region is to enhance stability of this secondary structure to ensure perpetuation of viral replication.
Since the initial reports of mutations in the pre-core region of hepatitis B virus (HBV) in hepatitis B e antigen (HBeAg)-negative (HBeAg-) patients with active liver disease (1, 2), numerous investigators from different parts ofthe world have reported the same mutation: G A change at nucleotide position 1896, creating a stop codon at codon 28 (3) (4) (5) (6) (7) (8) (9) (10) . This mutation leads to premature termination ofthe pre-core/core protein, thus preventing the production of HBeAg. The reason for the frequent detection of this mutation is postulated to be due to immune selection. Several studies have shown that HBeAg may be a target antigen on HBV-infected hepatocytes (11, 12) . Failure to produce a target antigen may be a means to evade immune clearance. Although mutations in other regions of the pre-core/core gene may also prevent production of HBeAg, practically all patients reported to date (except for one study) (13) had the same mutation: G -> A change at nucleotide position 1896. The predilection for this site is not clear. Some patients have an additional mutation: G -> A change at position 1899 (1, 3, 5, 7, 10, 13) . The significance of this mutation is unknown, since it is downstream of the stop codon mutation.
In an earlier report on a small number of Chinese patients (13), most of whom were HBeAg-, we found two unusual mutations-"M1," C --T change at position 1856 resulting in a Pro --Ser change at codon 15; and "M3," a G --A change at position 1898 resulting in a Gly -* Ser change at codon 29-in addition to the stop codon mutation (G -* A change at position 18%), which we called "M2," and the G A change at position 1899, which we called "M4." Ml and M2 were mutually exclusive. M3 was only found in association with Ml, and M4 was only found in association with M2. We hypothesized that Ml may prevent HBeAg secretion by blocking entry of the pre-core/core protein into the endoplasmic reticulum because of its close proximity to the signal peptide cleavage site at codon 19. We were unable to explain the mutual exclusion of Ml and M2 and the close association between Ml and M3 and between M2 and M4.
We have extended our study to include a larger number of patients to clarify: (i) the relation between Ml and HBeAg secretion, (ii) the role of Ml and M2 in the pathogenesis of liver disease, and (iii) the significance of M3 and M4. We also sought to confirm if Ml and M2 were truly mutually exclusive and to determine a biological basis for this phenomenon.
PATIENTS AND METHODS
Patients. Three hundred and eight Chinese patients from Hong Kong who had chronic HBV infection were studied: 201 were HBeAg-positive (HBeAg+) and 107 were HBeAg-. Patients with serum alanine aminotransferase (ALT) levels persistently below 1.5 times the upper limit of normal were considered to have inactive liver disease.
Methods. An aliquot of serum was collected at each clinic visit and stored at -200C for serum HBV DNA assay. The earliest available sample of residual sera from each patient was analyzed. Follow-up samples over a 1-to 7-year period from 101 patients were also analyzed to determine the time of appearance of each mutation and the correlation with HBe seroconversion.
DNA Extraction. Serum proteins were denatured by the addition of 2 pl of 1 M NaOH to 18 l of serum (14) . After a 1-hr incubation at 370C, the samples were neutralized with 20 1d of 0.1 M HC1. The samples were then centrifuged for (Fig. ld) was found in 10 (4%) patients as the only mutation or in association with Ml or M2. Thus, both nucleotides 1856 and 1858 could be T or C. The association with M2 was stronger than that with Ml or the wt sequence (P < 0.0001). Seven (70%) patients had concomitant M2, and all were HBeAg-. In these patients, M4 appeared to emerge later than M2, being detected in 29o of HBeAg-patients but in none of the HBeAg+ patients (P = 0.01). In (Fig. le) . This patient also had MO. He was HBeAg-and had active cirrhosis. One patient had M1 [A-k T change at position 1814 (Met-k Leu at codon 1), leading to loss of the start codon. This patient was HBeAg-and had active cirrhosis. One patient had M12 (insertion of A-A between positions 1817 and 1820, leading to a frameshift mutation creating a stop codon at codon 9). This patient was HBeAg-and had chronic active hepatitis.
DISCUSSION
In this extended study, we found that, as in our earlier report (13) , the most frequent missense or nonsense mutations in the pre-core region were Ml, M2, M3, and M4. We also confirmed that Ml and M2 are mutually exclusive and that M3 was found only in association with Ml. Although M4 was mainly found in association with M2, it was also found in association with Ml as well as wt sequence.
Our current data showed that Ml can be detected in similar proportions of HBeAg+ and HBeAg-patients and is unlikely to affect HBeAg secretion. Ml alone had no effect on the activity of liver disease, but the combination of Ml and M3 was frequently associated with active liver disease. The presence of M2 in HBeAg+ patients was associated with active liver disease in 95% of these patients and impending HBeAg clearance in 45%. In contrast, only 46% of HBeAgpatients with M2 had active liver disease. Thus, M2 on its own is not the cause of active liver disease, but the immune process by which wt sequence is eliminated and M2 is selected may be the responsible factor. M4 did not seem to confer increased risk of active liver disease in patients with 1896, 1855 with M2. 3 unpaired sites The most common conserved mutation was MO. A few while that on published sequences have also reported a C at position 1858 codons 28 and 2 (17) (18) (19) , so MO may be a common variant rather than a true and M4 change mutation. In view of the conserved nature ofthis change, MO limb from G to) was ignored in our earlier report. We were astonished that MO However, a G was present in 100%6 of patients with Ml even though codon reported, nor is 15 can be changed from encoding proline to encoding serine studied. This m with C --T change at position 1856 only (TCT also codes for which is situate serine). We were even more surprised by the complete outside the fun absence of MO in patients with M2. 1930) (20) of th The invariable coexistence ofcertain mutations in codon 15 Surprisingly, and codons 28 and 29 and the mutual exclusion of other of the three unj mutations in these two noncontiguous regions is intriguing.
would serve to 4 Revelation came from the paper by Junker-Niepmann et al.
found that 40%o (20) on the localization of a short cis-acting sequence for unpaired site (j HBV pre-genome encapsidation in the pre-core/core region.
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The authors found that this encapsidation sequence contains -+ A change in a number of inverted repeat sequences with the potential of of our patients forming secondary structures such as a stem-loop. Codon 15 Ml involves and codons 28 and 29 are in fact located opposite each other destroying the on the stem (Fig. 2) . Ogata et al. (21) showed that M2 and M4
1898. In our stu serve to stablize the stem. Tong et al. (22) other ethnic groups, other studies had a smaller number of patients, and some studies used biased techniques (hybridization with oligonucleotide probes corresponding to wt or the M2 sequence). Among 19 published complete HBV sequences, only 3 (16%) had MO (17) (18) (19) 21) . Of 13 studies on pre-core HBV mutations, only 3 (23%) reported the presence of MO in a small proportion of the clones sequenced (1, 3, 4, (7) (8) (9) (24) (25) (26) (27) (28) (29) (30) (31) . The single patient with coexistent M9 and M10 further illustrates the importance of base pairing in this stem-loop structure. These two mutations involve the replacement of the C-G pair between nucleotides 1857 and 1897 by a T-A pair. This patient also had MO, emphasizing that mutations that destabilize the 3-nt segment of the stem from position 1856 to 1858 and from 18% to 1898 can only occur if there are already two paired sites.
M4 provides base pairing between nucleotides 1855 and 1899, thus enhancing the stability of the stem-loop structure. It is located beyond the 3-nt segment that encompass MO, Ml, M2, and M3. Thus, it is not surprising that M4 can be associated with any of these mutations. However, it is unclear why M4 was more frequently associated with M2, nor is it known why M4 emerged later than M2.
The only other mutations involving the stem are M5a and Sb which change nucleotide 1846 from A to T or C, thus destroying base pairing at this site. However, compensatory mutations at nucleotide 1908 that would restore stability to this site were not observed. This may be related to the position of this site: at the mouth of the stem-loop structure, so the need for base pairing here is less critical; and the fact that this site is outside the functionally important region of the pre-genome encapsidation sequence. Furthermore, in some patients, M5a was only intermittently detected.
Some of the mutations identified in this study have been reported in other published full-length HBV sequences. Interestingly, MO and Ml were also not detected in the five sequences with M2 (31, (32) (33) (34) . However, neither Ml nor M3 was found in the three sequences with MO (17) (18) (19) . M9 was not detected in the two sequences with M10 (31), but both sequences had M2, again indicating that at least two of three sites in the 3-nt segment (1856-1858 and 1896-1898) need to be paired.
Our results support the proposed secondary structure of the pre-genome encapsidation sequence (20) and the importance of maintaining this secondary structure. Our data also suggest that the 3-nt segment (1856-1858 and 1896-1898) and perhaps the adjacent nucleotide (1855 or 1899) are crucial for the function ofthis encapsidation sequence, possibly because of its close proximity to the start codon of the core gene. The frequent occurrence of M2 and M4 is easy to understand, since they serve to stabilize the stem structure. However, the frequent occurrence of Ml, which destabilizes the stem structure, is intriguing. Although half of the patients with Ml had M3, a compensatory mutation that restores stability of the stem, we do not rule out the possibility that Ml and M3, both being missense mutations, have specific functional roles including modification of the secondary structure and hence biological effects of the pre-genome encapsidation sequence. The absence of mutations in the bulge (nucleotides 1860-1865) of this stem-loop structure may be related to the recent finding that mutations in this region can interfere with synthesis of minus-strand DNA (23) .
